Keith A. Jolley
Keith A. Jolley publishes mostly in Microbiology, Epidemiology and Molecular Biology, on topics such as Bacterial Infections and Vaccines, Pneumonia and Respiratory Infections and Salmonella and Campylobacter epidemiology.
- World rank
- #36,162 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #2,811 of 367,258
- Works
- 262
- Citations
- 22k
- Citations per work
- 83.7
What does Keith A. Jolley research?
Keith A. Jolley's work is mostly in Medicine (27%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences11142.5%
- Everything else8030.4%
- Health Sciences7127.1%
- Medicine7127.1%
- 1Microbiology20% of their works
- 2Epidemiology19% of their works
- 3Molecular Biology10% of their works
- 4Infectious Diseases8% of their works
- 5Food Science7% of their works
- 6Endocrinology6% of their works
Research topics
- Bacterial Infections and Vaccines
- Pneumonia and Respiratory Infections
- Salmonella and Campylobacter epidemiology
- Genomics and Phylogenetic Studies
- Infective Endocarditis Diagnosis and Management
- Antimicrobial Resistance in Staphylococcus
- Streptococcal Infections and Treatments
- Antibiotic Resistance in Bacteria
Which keywords describe Keith A. Jolley's research?
The keywords of their largest research topics: Epidemiology, Antimicrobial Resistance, Clinical Management, Pathogenesis, Bacterial Meningitis, Neisseria meningitidis, Community-Acquired Pneumonia and Pneumococcal Conjugate Vaccine.
- Antibiotic Resistance
- Staphylococcus aureus
- MRSA
- Diagnosis
- RNA-Seq
- Campylobacter
- Pneumococcal Conjugate Vaccine
- Neisseria meningitidis
- Pathogenesis
- Antimicrobial Resistance
- Epidemiology
- Clinical Management
- Bacterial Meningitis
- Community-Acquired Pneumonia
- Virulence Factors
- Salmonella
- sequence alignment
- Infective Endocarditis
- Necrotizing Fasciitis
- Streptococcus Pyogenes
- Multidrug-Resistant Bacteria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology2766 topics
- Antimicrobial Resistance1333 topics
- Clinical Management1192 topics
- Pathogenesis1192 topics
- Bacterial Meningitis981 topic
- Neisseria meningitidis981 topic
- Community-Acquired Pneumonia721 topic
- Pneumococcal Conjugate Vaccine721 topic
- Virulence Factors422 topics
- Campylobacter401 topic
- Salmonella401 topic
- RNA-Seq361 topic
- sequence alignment361 topic
- Diagnosis241 topic
- Infective Endocarditis241 topic
- MRSA211 topic
- Necrotizing Fasciitis211 topic
- Staphylococcus aureus211 topic
- Streptococcus Pyogenes211 topic
- Antibiotic Resistance201 topic
- Multidrug-Resistant Bacteria201 topic
Where does Keith A. Jolley work?
Keith A. Jolley's main affiliation in the publication record is University of Oxford, United Kingdom.
How many publications and citations does Keith A. Jolley have?
OpenAlex counts 262 works and 21,939 citations for Keith A. Jolley, an h-index of 66, ranking #36,162 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Keith A. Jolley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.